Compound Detail
CHEMBL4213671
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4213671 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | NTLMMHADDCGYAL-UHFFFAOYSA-N |
2
Targets
5
Activities
1
Assay Types
0
PK Parameters
12
Publications
0
Known Names
Molecular Properties
406.3
MW (Da)
3.00
ALogP
3
HBA
1
HBD
66.5
PSA (Ų)
0.79
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 5 meas. best 6.05
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Hepatitis B virus CHEMBL613497 | EC50 | 6.05 | 5.9525 | 900.0 | 4 |
| Core antigen CHEMBL1075091 | EC50 | 6.0 | 6.0 | 1000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Hepatitis B virus | EC50 | = | 900.0 | nM | 6.05 | Antiviral activity against HBV infected in human HepAD38 cells assessed as reduc... | 28688280 |
| Core antigen | EC50 | = | 1000.0 | nM | 6.0 | Inhibition of capsid in HBV infected in human HepAD38 cells assessed as reductio... | 28688280 |
| Hepatitis B virus | EC50 | = | 1200.0 | nM | 5.92 | Antiviral activity against HBV infected in human HepAD38 cells assessed as reduc... | 28688280 |
| Hepatitis B virus | EC50 | = | 1200.0 | nM | 5.92 | Antiviral activity against HBV infected in human HepAD38 cells assessed as reduc... | 28688280 |
| Hepatitis B virus | EC50 | = | 1200.0 | nM | 5.92 | Antiviral activity against Hepatitis B virus infected in human HePAD38 cells ass... | 33421915 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 28688280 | 10.1016/j.ejmech.2017.06.062 | Hepatitis B virus | 6 |
| 28688280 | 10.1016/j.ejmech.2017.06.062 | Core antigen | 3 |
| 33421915 | 10.1016/j.bmc.2020.115952 | Hepatitis B virus | 2 |
| 28688280 | 10.1016/j.ejmech.2017.06.062 | PBMC | 1 |
| 28688280 | 10.1016/j.ejmech.2017.06.062 | CCRF-CEM | 1 |
| 28688280 | 10.1016/j.ejmech.2017.06.062 | Vero | 1 |
| 28688280 | 10.1016/j.ejmech.2017.06.062 | HepG2 | 1 |
| 28688280 | 10.1016/j.ejmech.2017.06.062 | Unchecked | 1 |
| 33421915 | 10.1016/j.bmc.2020.115952 | Unchecked | 1 |
| 33421915 | 10.1016/j.bmc.2020.115952 | CCRF-CEM | 1 |
| 33421915 | 10.1016/j.bmc.2020.115952 | Vero | 1 |
| 33421915 | 10.1016/j.bmc.2020.115952 | HepG2 | 1 |
Data from ChEMBL 36 via Core Engine